Загрузка...
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
Tumour resistance to radiotherapy remains a barrier to improving cancer patient outcomes. To overcome radioresistance, certain drugs have been found to sensitize cells to ionizing radiation (IR). In theory, more potent radiosensitizing drugs should increase tumour kill and improve patient outcomes....
Сохранить в:
| Опубликовано в: : | Nat Commun |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5059467/ https://ncbi.nlm.nih.gov/pubmed/27698471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms13019 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|